Valeant Pharmaceuticals Pharma is increasingly encroaching on device makers’ territory, but that strategy may have backfired for one drug company that tried to jump on the bandwagon.
News & Features
Women's Health Devices Women’s health devices came under closer scrutiny this year.
It would be a merry Christmas indeed if the medtech industry woke up to these things under the tree on December 25.
Healthcare experts predict that Amazon will formally enter the healthcare marketplace in 2015 and the move will be disruptive.
Johnson & Johnson's n ew product launches in the surgical, trauma, diabetes, and ophthalmology spaces.
J&J is working with Google to make surgical robotic systems smarter, smaller, cheaper, and, ultimately, more accessible.
The agency recently denied three petitions seeking to ban mercury-based dental amalgams, which some studies have linked to kidney damage and neurological disabilities and diseases.
Medtronic and Covidien consummate their $49.9 billion deal and offer a subtle but profound change in the way the combined company will do business.
The trend of mega deals in the medtech world continues with Johnson & Johnson and Boston Scientific announcing billion-dollar deals.
Omar Ishrak believes that digital health and mobile health technologies will enable the much-needed evolution of medtech.
Omar Ishrak, CEO of Medtronic, is steering the largest pure-play medtech company at a time of great tumult and change in the industry. In a wide-ranging interview, Ishrak provides answers about the future of medtech and much more.